Does the Evidence Support the Use of Concurrent Chemoradiotherapy as a Standard in the Management of Locally Advanced Cancer of the Cervix, Especially in Developing countries?

Clinical Oncology

Volumn 18, Issue 4, 2006, Pages 306-312

  Datta, N R ^a   Agrawal, S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer cervix; chemoradiotherapy; clinical trials; developing countries; radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; HYDROXYUREA; MITOMYCIN C;

ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DEVELOPING COUNTRY; EVIDENCE BASED MEDICINE; FEMALE; GASTROINTESTINAL DISEASE; HEALTH CARE ORGANIZATION; HEMATOLOGIC DISEASE; HUMAN; KIDNEY DISEASE; MEDICAL DECISION MAKING; META ANALYSIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; PATIENT CARE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

COMBINED MODALITY THERAPY; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PATIENT CARE MANAGEMENT; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; UTERINE CERVICAL NEOPLASMS;

EID: 33645864380     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.12.005     Document Type: Article

References (47)

1. In: Stewart B.W., and Kleihues P. (Eds). World cancer report (2003), IARC Press, Lyon 215-222
2. Thomas G.M. Improved treatment for cervical cancer: concurrent chemotherapy and radiotherapy. N Engl J Med 340 (1999) 1198-1199
3. Waggoner S.E. Cervical cancer. Lancet 361 (2003) 2217-2225
4. Coia L., Won M., Lanciano R., Marcial V.A., Martz K., and Hanks G. The patterns of care outcome study for cancer of the uterine cervix: results of a second national practice survey. Cancer 66 (1990) 2451-2456
5. Fyles A.W., Pintilie M., Kirkbride P., Levin W., Manchul L.A., and Rawlings G.A. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 35 (1995) 107-117
6. Horiot J.C., Pigneux J., Pourquier H., et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to the G.H. Fletcher guidelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 14 (1988) 605-611
7. Ferrigno R., Campos de Oliveira Faria S.L., Weltman E., et al. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low dose rate brachytherapy: retrospective analysis of results and variables. Int J Radiat Oncol Biol Phys 55 (2003) 695-706
8. Nakano T., Kato S., Ohno T., et al. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer 103 (2005) 92-101
9. Criaghead P.S., Smulian H.G., deGroot H.J., and duToit P.F.M. Are recommendations from carcinoma of the cervix patterns of care studies (PCS) in the United States of America (USA) applicable to centres in developing countries?. Int J Radiat Oncol Biol Phys 37 (1997) 803-810
10. Saibeshkumar E.P., Patel F.D., and Sharma S.C. Results of a phase II trial of concurrent chemoradiation in the treatment of locally advanced carcinoma of uterine cervix: an experience from India. Bull Cancer 92 (2005) E7-E12
11. Datta N.R., Pasricha R., Singh U., and Srivastava A. Predictors of survival endpoints in patients with cancer of the cervix on long-term follow-up; inferences and implications from an audit of patients treated with a specific radiotherapy protocol. Clin Oncol 16 (2004) 536-542
12. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
13. Peters III W.A., Liu P.Y., Barrett II R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with radiotherapy alone as adjuvant therapy after radical surgery in high-risk early stage-cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
14. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
15. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
16. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
17. Cancer trials. NCI issues clinical announcement on cervical cancer - chemotherapy plus radiation improves survival (Feb 22, 1999). http://www.cancer.gov.newscenter/cervicalcancer.html (last accessed Jan 2006)
18. Eifel P.J., Moughan J., Erickson B., Larocci T., Grant D., and Owen J. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. Int J Radiat Oncol Biol Phys 60 (2004) 1144-1153
19. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systemic review and meta-analysis. Lancet 358 (2001) 781-786
20. Therasse P. From clinical trials to evidence-based medicine: how to build the evidence. Eur J Cancer 1 Suppl (2003) 55-65
21. Perez C.A., and Kavanagh B.D. Gynecologic tumors. In: Perez C.A., Brady L.W., Halperin E.C., and Schmidt-Ullrich R.K. (Eds). Principles and practice of radiation oncology. 4th edn (2004), Lippincott Williams and Wilkins, Philadelphia 1800-1916
22. Hanks G.E., Herring D.F., and Kramer S. Patterns of care outcome studies: results of the national practice in cancer of the cervix. Cancer 51 (1983) 959-967
23. Lwanga S.K., and Lameshow S. Sample size determination in health studies: a practical manual (1991), WHO, Geneva
24. Bentzen S.M. A user's guide to evidence-based oncology. Eur J Cancer 1 Suppl (2003) 77-91
25. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
26. Hreshchyshyn M.M., Aron B.S., Boronow R.C., Franklin E.W., Shingleton H.M., and Blessing J.A. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 5 (1979) 317-322
27. Lukka H., Hirte H., Fyles A., et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer - a meta-analysis. Clin Oncol 14 (2002) 203-212
28. Symonds P., Kirwan J., Williams C., et al. Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix. The Cochrane Library Issue 1 (2004), Chichester John Wiley and Sons, Ltd, Chichester
29. Thomas G., Dembo A., Ackerman I., et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 69 (1998) 137-148
30. Green J., Kirwan J., Tierney J., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. The Cochrane Library Issue 3 (2005), Chichester: John Wiley and Sons, Ltd, Chichester
31. Wong L.C., Choo Y.C., Choy D., Sham J.S.T., and Ma H.K. Long term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecol Oncol 35 (1989) 159-163
32. Tseng C.-J., Chang C.-T., Lai C.-H., et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 66 (1997) 52-58
33. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20 (2002) 966-972
34. Rose P.G. Chemoradiotherapy for cervical cancer. Radiother Oncol 38 (2002) 270-278
35. Szumiel I., and Nias A.H.W. The effect of combined treatment with a platinum complex and ionizing radiation on Chinese hamster ovary cells in vitro. Br J Cancer 33 (1976) 450-458
36. Douple E.B., and Richmond R.C. Radiosensitization of hypoxic tumor cells by cis and trans-dichlorodiamineplatinum (II). Int J Radiat Oncol Biol Phys 5 (1979) 1369-1372
37. Gasinska A., Fowler J.F., Lind B.K., and Urbanski K. Influence of overall time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. Acta Oncol 43 (2004) 657-666
38. Borowsky M.E., Elliott K.S., Pezzullo J.C., et al. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer. Bull Cancer 92 (2005) E19-E24
39. Saibishkumar E.P., Lal P., Tiwari A., et al. Chemoradiation versus radiotherapy alone in locally advanced carcinoma of the uterine cervix - an ongoing phase III trial. Radiother Oncol 73 Suppl 1 (2004) S293
40. Durand R.E., and Aquino-Parsons C. Predicting response to treatment in human cancers of the uterine cervix: sequential biopsies during external beam radiotherapy. Int J Radiat Oncol Biol Phys 58 (2004) 555-560
41. Thomas G.M. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol 10 (2000) 44-50
42. Nagar Y.S., Singh S., Kumar S., and Lal P. Conventional 4-field box radiotherapy technique for cancer cervix: potential for geographic miss without CECT scan-based planning. Int J Gynecol Cancer 14 (2004) 865-870
43. Datta N.R. From 'points' to 'profiles' in intracavitary brachytherapy of cervix. Curr Opin Obstet Gynecol 17 (2005) 35-41
44. Nag S., Cardenes H., Chang S., et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys 60 (2004) 1160-1172
45. Urbanski K., Gasinska A., Pudelek J., Fowler J.F., Lind B., and Brahme A. Biologically effective doses in radiotherapy of cervical carcinoma. Neoplasma 51 (2004) 228-238
46. Singh S., Datta N.R., Krishnani N., Lal P., and Kumar S. Radiation therapy induced micronuclei in cervical cancer: does it have a predictive value for local disease control?. Gynecol Oncol 97 (2005) 764-771
47. Lorvidhaya V., Chitapanarux I., Sangruchi S., et al. Concurrent mitomycin C, 5-fluorouracil and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 1226-1232